Think

Bowing to Trump, Novartis Joins Pfizer in Freezing Drug Prices

F.D.A. Names and Shames Drug Makers to Encourage Generic Competition

F.D.A. Panel Recommends Approval of Cannabis-Based Drug for Epilepsy

Medicare Is Cracking Down on Opioids. Doctors Fear Pain Patients Will Suffer.

The Price They Pay

F.D.A. Chief Goes Against the Administration Stereotype

New Index Rates Drug Companies in Fight Against ‘Superbugs’

Young Women Are Using A.D.H.D. Drugs in Greater Numbers, C.D.C. Reports

Nearly 21 Million Now Receiving AIDS Drugs, U.N. Agency Says

Patents For Restasis Are Invalidated, Opening Door to Generics

In Early Results, Shorter Treatment for Tuberculosis Proves Effective

As Cancer Tears Through Africa, Drug Makers Draw Up a Battle Plan

Amid Opioid Crisis, Insurers Restrict Pricey, Less Addictive Painkillers

Hospitals Are Clogged With Patients Struggling With Opioids

A Cancer Conundrum: Too Many Drug Trials, Too Few Patients

Rapid Malaria Tests Work, but With Unexpected Drawbacks

Consensus Is Health Law Can Be Fixed. Now the Hard Part.

14 Years Old. Losing Muscle Every Day.

A Look at Major Drug-Pricing Proposals

A Vital Drug Runs Low, Though Its Base Ingredient Is in Many Kitchens